esterbut-3 has been researched along with tetradecanoylphorbol acetate in 1 studies
| Studies (esterbut-3) | Trials (esterbut-3) | Recent Studies (post-2010) (esterbut-3) | Studies (tetradecanoylphorbol acetate) | Trials (tetradecanoylphorbol acetate) | Recent Studies (post-2010) (tetradecanoylphorbol acetate) |
|---|---|---|---|---|---|
| 10 | 0 | 0 | 31,050 | 61 | 2,217 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belpomme, D; Calabresse, C; Chomienne, C; Ronco, G; Venturini, L; Villa, P | 1 |
1 other study(ies) available for esterbut-3 and tetradecanoylphorbol acetate
| Article | Year |
|---|---|
Butyric acid and its monosaccharide ester induce apoptosis in the HL-60 cell line.
Topics: Antineoplastic Agents; Apoptosis; Butyrates; Butyric Acid; Cell Line; Cell Survival; DNA, Neoplasm; Glucose; Humans; Leukemia, Promyelocytic, Acute; Monosaccharides; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1993 |